Loading...

Jesse Lee Berry, MD

TitleAssistant Professor of Clinical Ophthalmology
InstitutionUniversity of Southern California
DepartmentPediatrics
AddressCHL 4650 Sunset Blvd
Off Campus
Los Angeles CA 90027
Phone+1 323 442 6578
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard UniversityBA2004
    Harvard Medical SchoolMD2008
    USC Roski Eye InstituteOphthalmology Residency2012
    Children's Hospital Los AngelesOcular Oncology Fellowship2014
    Collapse Awards and Honors
    2000  - 2004Harvard College Scholarship: Elizabeth Cary Agassiz Scholar
    2000  - 2004Malcolm Kinsberg Scholarship
    2002Kappa Alpha Theta Foundation Scholarship
    2003David Rockefeller Center of Latin American Studies Grant
    2004  - 2008Nevil & Louise Ford Scholarship Fund
    2005Harvard Medical International Initiatives in Research Grant
    2007Center for Eye Research and Education McCleary Grant
    2011Doheny Eye Institute Medical Knowledge Award
    2012Starr Schulman Fellowship
    2012Department of Health Services Innovation Grant
    2013Society of Heed Fellows
    2013  - 2014University of Southern California Excellence in Resident Teaching Award

    Collapse Overview 
    Collapse Overview
    Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Jonathan Kim and A. Linn Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

    Evaluation of the aqueous humor for tumor-derived genetic information and its application to prognosis and precision medicine for retinoblastoma patients. Investigating new methods of chemotherapy delivery for the treatment of Retinoblastoma. Evaluating treatment outcomes for Retinoblastoma eyes. This includes evaluation of treatment outcomes after systemic chemotherapy and the elucidation of factors present at diagnosis, which contribute to final visual outcome in eyes treated for retinoblastoma.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry J. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Brachytherapy. 2018 Aug 03. PMID: 30082188.
      View in: PubMed
    2. Berry J, Xu L, Kooi I, Murphree AL, Prabakar RK, Reid MW, Stachelek K, Le BHA, Welter L, Reiser BJ, Chevez-Barrios P, Jubran R, Lee TC, Kim JW, Kuhn P, Cobrinik D, Hicks J. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Mol Cancer Res. 2018 Jul 30. PMID: 30061186.
      View in: PubMed
    3. Bellerive C, Berry J, Polski A, Singh AD. Conjunctival Squamous Neoplasia: Staging and Initial Treatment. Cornea. 2018 May 31. PMID: 29863543.
      View in: PubMed
    4. Shah S, Koban Y, Le BHA, Bechtold M, Zolfaghari E, Kim JW, Berry J. Iris Hypoplasia as the Presenting Sign of Retinoblastoma in a Child With a 13q Deletion. J Pediatr Ophthalmol Strabismus. 2018 Apr 23; 55:e10-e13. PMID: 29684226.
      View in: PubMed
    5. Berry J, Cobrinik D, Hicks J. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma-Reply. JAMA Ophthalmol. 2018 Mar 22. PMID: 29566117.
      View in: PubMed
    6. Lang P, Kim JW, McGovern K, Reid MW, Subramanian K, Murphree AL, Berry J. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications. Orbit. 2018 Feb 20; 1-6. PMID: 29461921.
      View in: PubMed
    7. Berry J, Lewis L, Zolfaghari E, Green S, Le BHA, Lee TC, Murphree AL, Kim JW, Jubran R. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing. Ophthalmic Genet. 2018 Jun; 39(3):407-409. PMID: 29286867.
      View in: PubMed
    8. Berry J, Kogachi K, Jubran R, Kim JW. Loss of fundus view as an indication for secondary enucleation in retinoblastoma. Pediatr Blood Cancer. 2018 Apr; 65(4). PMID: 29218818.
      View in: PubMed
    9. Francis JH, Abramson DH, Ji X, Shields CL, Teixeira LF, Schefler AC, Cassoux N, Hadjistilianou D, Berry J, Frenkel S, Munier FL. Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy. JAMA Ophthalmol. 2017 12 01; 135(12):1426-1429. PMID: 29098285.
      View in: PubMed
    10. Berry J, Xu L, Murphree AL, Krishnan S, Stachelek K, Zolfaghari E, McGovern K, Lee TC, Carlsson A, Kuhn P, Kim JW, Cobrinik D, Hicks J. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma. JAMA Ophthalmol. 2017 Nov 01; 135(11):1221-1230. PMID: 29049475.
      View in: PubMed
    11. Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry J, Lee DK, Rico G, Madi I, Rao N, Stachelek K, Wang LC, Gomer C. Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft. Graefes Arch Clin Exp Ophthalmol. 2017 Dec; 255(12):2363-2373. PMID: 28971251.
      View in: PubMed
    12. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry J. Three presentations of CNS disease in patients with intraocular retinoblastoma at a tertiary medical center in the United States. Ophthalmic Genet. 2018 Jan-Feb; 39(1):115-119. PMID: 28949779.
      View in: PubMed
    13. Berry J, Anulao K, Kim JW. Optical Coherence Tomography Imaging of a Large Spherical Seed in Retinoblastoma. Ophthalmology. 2017 08; 124(8):1208. PMID: 28734334.
      View in: PubMed
    14. Mustafi D, Damato B, Berry J. Unilateral Multifocal Choroidal Melanoma. Ocul Oncol Pathol. 2017 Dec; 4(1):48-51. PMID: 29344499.
      View in: PubMed
    15. Berry J, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatr Blood Cancer. 2017 Dec; 64(12). PMID: 28646513.
      View in: PubMed
    16. Berry J, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 Dec; 124(12):1817-1825. PMID: 28655537.
      View in: PubMed
    17. Berry J, Zolfaghari E, Chen A, Murphree AL, Jubran R, Kim JW. Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion? Ocul Oncol Pathol. 2017 Nov; 3(4):283-291. PMID: 29344482.
      View in: PubMed
    18. Wong BJ, Berry J. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan 12; 135(1):e164656. PMID: 28030719.
      View in: PubMed
    19. Berry J, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 Apr; 64(4). PMID: 28221729.
      View in: PubMed
    20. Aziz HA, Kim JW, Munier FL, Berry J. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan; 3(1):34-40. PMID: 28275601.
      View in: PubMed
    21. Berry J, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 12; 37(4):400-403. PMID: 26934665.
      View in: PubMed
    22. Berry J, Cobrinik D, Kim JW. Detection and Intraretinal Localization of an 'Invisible' Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr; 2(3):148-52. PMID: 27239455; PMCID: PMC4881267.
    23. Zhu D, Berry J, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. PMID: 27172535; PMCID: PMC4847672.
    24. Jacobsen BH, Berry J, Jubran R, Kim JW. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec; 2(2):76-9. PMID: 27171650; PMCID: PMC4847708.
    25. Berry J, Kim JW, Jennelle R, Astrahan M. Use of the Toric Surgical Marker to Aid in Intraoperative Plaque Placement for the USC Eye Physics Plaques to Treat Uveal Melanoma: A New Surgical Technique. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep; 46(8):866-70. PMID: 26431303.
      View in: PubMed
    26. Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, Kampp TD, Astrahan MA, Kim JW, Berry J. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015 Sep-Oct; 14(5):718-25. PMID: 26073224.
      View in: PubMed
    27. Berry J, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. PMID: 27172253; PMCID: PMC4847682.
    28. Liu W, Rootman DB, Berry J, Hwang CJ, Goldberg RA. Methicillin-resistant Staphylococcus aureus dacryoadenitis. JAMA Ophthalmol. 2014 Aug; 132(8):993-5. PMID: 24875129.
      View in: PubMed
    29. Berry J, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Br J Ophthalmol. 2014 Aug; 98(8):1061-5. PMID: 24671926.
      View in: PubMed
    30. Berry J, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, Kim JW. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. JAMA Ophthalmol. 2013 Nov; 131(11):1435-42. PMID: 24008431.
      View in: PubMed
    31. Berry J, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013 Apr; 60(4):688-93. PMID: 22997170.
      View in: PubMed
    32. Berry J, Cuzzo LM, Bababeygy SR, Quiros PA. Unmet need for corrective eyeglasses: results from a Los Angeles County Hospital survey. Int Ophthalmol. 2012 Jun; 32(3):245-50. PMID: 22487855.
      View in: PubMed
    33. Lee NG, Berry J, Lee TC, Wang AT, Honowitz S, Murphree AL, Varshney N, Hinton DR, Fawzi AA. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3868-73. PMID: 21273549; PMCID: PMC3109062.
    34. Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, Char DH, Folberg R, Imhof SM, Lin AY, Berry J, Al Mesfer S, Moll AC, Abramson DH. Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J. 2011 Jan 18; 5:1-5. PMID: 21399766; PMCID: PMC3052645.
    35. Brauner SC, Berry J, Pye J, Lee EG, Rhee DJ. Effect of saline conditions on the tensile strength of ophthalmic sutures. Ophthalmic Surg Lasers Imaging. 2011 Mar-Apr; 42(2):148-51. PMID: 21117584.
      View in: PubMed
    Jesse's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _